Time for a bit of damage control!
On Monday Martin Shkreli — the former hedge fund manager and current CEO of Turing Pharmaceuticals announced that he'd be raising the price of the recently purchased drug Daraprim — a medication that helps people with weakened immune system such as AIDS patients or pregnant women.
There was a huge public outcry after people learned he was raising the price from $13.50 to $750 per pill!Related: Desperate Father Says He Robbed Bank To Pay For Baby Daughter's Cancer Treatment!
Well
apparently he's had a change of heart as the CEO announced he would be
lowering the price, saying the new cost would be figured out in the next
few weeks.
His
decision to flip flop isn't surprising; he faced an understandably
vicious backlash after the 5500% increase was reported. He said: Read more »
No comments:
Post a Comment